220 related articles for article (PubMed ID: 9257891)
1. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
3. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
[TBL] [Abstract][Full Text] [Related]
4. [Dynamic monitoring of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation by soluble HLA-I antigen detection].
Xia R; Qiu HY; Zhang WP; Cao Q; Lan JC; Wen HS; Wang JM
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):687-90, 695. PubMed ID: 15958310
[TBL] [Abstract][Full Text] [Related]
5. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
Russell CA; Heilmann C; Madsen HO; Vindeløv LL
Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
[TBL] [Abstract][Full Text] [Related]
7. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
[TBL] [Abstract][Full Text] [Related]
8. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
9. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
12. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
[TBL] [Abstract][Full Text] [Related]
13. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
14. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
15. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
16. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
17. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
[TBL] [Abstract][Full Text] [Related]
18. Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.
Mauz-Körholz C; Körholz D; Burdach S
J Lab Clin Med; 1995 Aug; 126(2):144-50. PubMed ID: 7636387
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
Nagler A; Bishara A; Brautbar C; Barak V
Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
[TBL] [Abstract][Full Text] [Related]
20. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
